In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EyeGate Pharmaceuticals Inc.

www.eyegatepharma.com

Latest From EyeGate Pharmaceuticals Inc.

Eight Pivotal Trial Read-Outs Expected In Q3

A number of pivotal studies are expected to report top-line data in the third quarter. Here, with the help of Informa Pharma's Biomedtracker, we take a look at eight of those likely to be major catalysts for their sponsors.

Clinical Trials Research & Development

Pipeline Watch: Peficitinib, Ubrogepant, Apalutamide Phase III Read-Outs

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Deals Shaping The Medical Industry, July 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2017.

Deals BioPharmaceutical

Execs On The Move, April 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments Leadership
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • EyeGate Pharma
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • EyeGate Pharmaceuticals Inc.
  • Senior Management
  • Stephen From, Pres. & CEO
    Sarah Romano, CFO
    Brenda Mann, PhD, VP, R&D
    Barbara Wirosko, MD, CMO
    Mike Garanzini, Chief Commercial Officer
  • Contact Info
  • EyeGate Pharmaceuticals Inc.
    Phone: (781) 788-8869
    271 Waverley Oaks Rd., Ste. 108
    Waltham, MA 02452
    USA
UsernamePublicRestriction

Register